• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Alkermes plc (ALKS)

    -NasdaqGS
    58.88 Up 1.20(2.08%) 4:00PM EST
    |After Hours : 58.88 Down 0.00 (0.00%) 6:33PM EST
    Add to Portfolio
    Prev Close:57.68
    Open:57.78
    Bid:49.80 x 1000
    Ask:59.87 x 200
    1y Target Est:53.25
    Beta:1.85
    Next Earnings Date:N/A
    Day's Range:56.82 - 59.00
    52wk Range:38.49 - 59.69
    Volume:1,722,870
    Avg Vol (3m):869,412
    Market Cap:8.61B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 2.08%8.61B
    ABTUp 0.61%69.34B
    LLYDown 0.07%77.44B
    GSKUp 0.14%104.21B

    Key Statistics

    Forward P/E (1 yr):189.94
    P/S (ttm):14.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.27
    Quarterly EPS Est (Dec-14) :0.03
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):32.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback